Dare Bioscience (DARE) Misses Q1 EPS by 50c

Dare Bioscience (NASDAQ: DARE) reported Q1 EPS of ($0.50). Revenue for the quarter came in at $25.42 million.

For earnings history and earnings-related data on Dare Bioscience (DARE) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Venu Holding enters $250 million at-the-market stock offering agreement
• Lockheed Martin wins $2.8B in Defense contracts for F-35, helicopters